The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues.
作者信息
Sanguedolce Francesca, Cormio Luigi
机构信息
Department of Pathology, University Hospital, Foggia, Italy.
Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.
出版信息
Transl Androl Urol. 2018 May;7(Suppl 2):S248-S251. doi: 10.21037/tau.2018.05.07.
Abstract
摘要
相似文献
1
The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues.上尿路与膀胱癌之间的复杂关系：临床及预测问题
Transl Androl Urol. 2018 May;7(Suppl 2):S248-S251. doi: 10.21037/tau.2018.05.07.
2
Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence.经尿道膀胱肿瘤切除术时切除远端输尿管壁内段：预测继发性狭窄和上尿路复发的因素。
J Urol. 2016 Jul;196(1):52-6. doi: 10.1016/j.juro.2016.01.038. Epub 2016 Jan 21.
3
Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.根治性肾输尿管切除术治疗上尿路上皮癌后既往、同期或随后膀胱癌对预后的影响。
J Urol. 2019 Dec;202(6):1127-1135. doi: 10.1097/JU.0000000000000422. Epub 2019 Jun 28.
4
Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.膀胱癌根治性膀胱切除术后上尿路复发：13185 例患者的荟萃分析。
J Urol. 2012 Dec;188(6):2046-54. doi: 10.1016/j.juro.2012.08.017. Epub 2012 Oct 18.
5
6
Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors.上尿路肿瘤及后续膀胱肿瘤中不同的微卫星改变。
J Urol. 2001 Feb;165(2):672-7. doi: 10.1097/00005392-200102000-00092.
7
A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.膀胱与上尿路移行细胞癌的病理学比较。
BJU Int. 2005 Apr;95(6):791-3. doi: 10.1111/j.1464-410X.2005.05402.x.
8
Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?膀胱癌根治性膀胱切除术后上尿路复发——哪些人有风险？
J Urol. 2009 Dec;182(6):2632-7. doi: 10.1016/j.juro.2009.08.046.
9
Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract.淋巴结切除术在膀胱和上尿路尿路上皮癌治疗中的作用。
Int J Urol. 2012 Aug;19(8):710-21. doi: 10.1111/j.1442-2042.2012.03009.x. Epub 2012 Apr 19.
10
[Upper urinary tract tumors following bladder cancer].[膀胱癌继发上尿路肿瘤]
Nihon Hinyokika Gakkai Zasshi. 1990 Sep;81(9):1362-6. doi: 10.5980/jpnjurol1989.81.1362.
引用本文的文献
1
Real-World Study of Treatment with Pembrolizumab Among Patients with Advanced Urothelial Tract Cancer in Denmark.丹麦晚期尿路上皮癌患者使用帕博利珠单抗治疗的真实世界研究。
Bladder Cancer. 2021 Dec 13;7(4):413-425. doi: 10.3233/BLC-211523. eCollection 2021.
2
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis.荧光原位杂交（FISH）在上尿路尿路上皮癌（UTUC）中的诊断性能：系统评价和荟萃分析。
Int J Clin Oncol. 2022 Oct;27(10):1605-1615. doi: 10.1007/s10147-022-02216-7. Epub 2022 Jul 18.
3
Non-Invasive Biomarkers in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma-A Systematic Review.非侵入性生物标志物在上尿路尿路上皮癌诊断中的系统评价
Cancers (Basel). 2022 Mar 16;14(6):1520. doi: 10.3390/cancers14061520.
4
The incidence and prevalence of upper tract urothelial carcinoma: a systematic review.上尿路尿路上皮癌的发病率和患病率：一项系统评价
BMC Urol. 2021 Aug 17;21(1):110. doi: 10.1186/s12894-021-00876-7.
本文引用的文献
1
Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.根治性肾输尿管切除术治疗上尿路上皮癌后膀胱内卡介苗治疗后续非肌层浸润性膀胱癌的结果。
BJU Int. 2018 May;121(5):764-773. doi: 10.1111/bju.14111. Epub 2018 Jan 21.
2
Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience.上尿路尿路上皮癌手术治疗后膀胱内复发的危险因素及预后：一项30年单中心经验
Arab J Urol. 2017 May 9;15(3):216-222. doi: 10.1016/j.aju.2017.03.006. eCollection 2017 Sep.
3
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南：2017 年更新版。
Eur Urol. 2018 Jan;73(1):111-122. doi: 10.1016/j.eururo.2017.07.036. Epub 2017 Sep 1.
4
Upper tract urothelial carcinoma: a different disease entity in terms of management.上尿路尿路上皮癌：在治疗方面是一种不同的疾病实体。
ESMO Open. 2017 Jan 24;1(6):e000126. doi: 10.1136/esmoopen-2016-000126. eCollection 2016.
5
Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.诊断性输尿管镜检查对上尿路尿路上皮癌根治性肾输尿管切除术患者膀胱内复发的影响：一项系统评价和荟萃分析。
BJU Int. 2017 Sep;120(3):313-319. doi: 10.1111/bju.13935. Epub 2017 Jul 19.
6
Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌的全面基因组特征分析。
Eur Urol. 2017 Oct;72(4):641-649. doi: 10.1016/j.eururo.2017.05.048. Epub 2017 Jun 7.
7
Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.上尿路尿路上皮癌根治性肾输尿管切除术后术前肾功能和肉眼血尿对膀胱内复发的临床意义。
Int J Urol. 2017 Feb;24(2):111-116. doi: 10.1111/iju.13256. Epub 2016 Nov 22.
8
Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy.表皮生长因子受体和Ki-67作为预测性生物标志物可识别出对根治性肾输尿管切除术后预防膀胱癌复发的膀胱内灌注治疗更敏感的患者。
PLoS One. 2016 Nov 21;11(11):e0166884. doi: 10.1371/journal.pone.0166884. eCollection 2016.
9
Prevention of Recurrent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: An Individualized Selection Strategy Based on Patient Risk Stratification Is Needed.根治性肾输尿管切除术治疗原发性上尿路尿路上皮癌后复发性膀胱肿瘤的预防：需要基于患者风险分层的个体化选择策略。
Urol Int. 2017;98(3):312-319. doi: 10.1159/000451004. Epub 2016 Nov 15.
10
Why are upper tract urothelial carcinoma two different diseases?为什么上尿路尿路上皮癌是两种不同的疾病？
Transl Androl Urol. 2016 Oct;5(5):636-647. doi: 10.21037/tau.2016.03.23.
Zotero 插件